Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

1.

Isothermal switching and detailed filament evolution in memristive systems.

Mickel PR, Lohn AJ, James CD, Marinella MJ.

Adv Mater. 2014 Jul 9;26(26):4486-90. doi: 10.1002/adma.201306182. Epub 2014 Apr 29.

PMID:
24782402
[PubMed - in process]
2.

Immunocompetent murine models for the study of glioblastoma immunotherapy.

Oh T, Fakurnejad S, Sayegh ET, Clark AJ, Ivan ME, Sun MZ, Safaee M, Bloch O, James CD, Parsa AT.

J Transl Med. 2014 Apr 29;12:107. doi: 10.1186/1479-5876-12-107.

PMID:
24779345
[PubMed - in process]
Free PMC Article
3.

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.

Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ, Barani IJ, James CD, Parsa AT.

Neuro Oncol. 2014 May;16(5):628-36. doi: 10.1093/neuonc/nou025. Epub 2014 Apr 2.

PMID:
24696499
[PubMed - in process]
4.

Stainless steel versus titanium volar multi-axial locking plates for fixation of distal radius fractures: a randomised clinical trial.

Couzens GB, Peters SE, Cutbush K, Hope B, Taylor F, James CD, Rankin CR, Ross M.

BMC Musculoskelet Disord. 2014 Mar 11;15:74. doi: 10.1186/1471-2474-15-74.

PMID:
24612524
[PubMed - in process]
Free PMC Article
5.

Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype.

Fouse SD, Nakamura JL, James CD, Chang S, Costello JF.

Neuro Oncol. 2014 Mar;16(3):361-71. doi: 10.1093/neuonc/not223. Epub 2013 Dec 4.

PMID:
24311636
[PubMed - in process]
6.

Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.

Nathanson DA, Gini B, Mottahedeh J, Visnyei K, Koga T, Gomez G, Eskin A, Hwang K, Wang J, Masui K, Paucar A, Yang H, Ohashi M, Zhu S, Wykosky J, Reed R, Nelson SF, Cloughesy TF, James CD, Rao PN, Kornblum HI, Heath JR, Cavenee WK, Furnari FB, Mischel PS.

Science. 2014 Jan 3;343(6166):72-6. doi: 10.1126/science.1241328. Epub 2013 Dec 5.

PMID:
24310612
[PubMed - indexed for MEDLINE]
7.

Targeting Wee1 for the treatment of pediatric high-grade gliomas.

Mueller S, Hashizume R, Yang X, Kolkowitz I, Olow AK, Phillips J, Smirnov I, Tom MW, Prados MD, James CD, Berger MS, Gupta N, Haas-Kogan DA.

Neuro Oncol. 2014 Mar;16(3):352-60. doi: 10.1093/neuonc/not220. Epub 2013 Dec 4.

PMID:
24305702
[PubMed - in process]
8.

Cidofovir: a novel antitumor agent for glioblastoma.

Hadaczek P, Ozawa T, Soroceanu L, Yoshida Y, Matlaf L, Singer E, Fiallos E, James CD, Cobbs CS.

Clin Cancer Res. 2013 Dec 1;19(23):6473-83. doi: 10.1158/1078-0432.CCR-13-1121. Epub 2013 Oct 29.

PMID:
24170543
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Frequent truncating mutations of STAG2 in bladder cancer.

Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, Volkmer B, Hautmann R, Küfer R, Hogendoorn PC, Netto G, Theodorescu D, James CD, Czerniak B, Miettinen M, Waldman T.

Nat Genet. 2013 Dec;45(12):1428-30. doi: 10.1038/ng.2800. Epub 2013 Oct 13.

PMID:
24121789
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas.

Gini B, Zanca C, Guo D, Matsutani T, Masui K, Ikegami S, Yang H, Nathanson D, Villa GR, Shackelford D, Zhu S, Tanaka K, Babic I, Akhavan D, Lin K, Assuncao A, Gu Y, Bonetti B, Mortensen DS, Xu S, Raymon HK, Cavenee WK, Furnari FB, James CD, Kroemer G, Heath JR, Hege K, Chopra R, Cloughesy TF, Mischel PS.

Clin Cancer Res. 2013 Oct 15;19(20):5722-32. doi: 10.1158/1078-0432.CCR-13-0527. Epub 2013 Sep 12.

PMID:
24030701
[PubMed - indexed for MEDLINE]
11.

Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.

Lowe DM, Rangaka MX, Gordon F, James CD, Miller RF.

PLoS One. 2013 Aug 2;8(8):e69969. doi: 10.1371/journal.pone.0069969. Print 2013. Review.

PMID:
23936365
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18.

Delury CP, Marsh EK, James CD, Boon SS, Banks L, Knight GL, Roberts S.

J Virol. 2013 Sep;87(17):9463-72. doi: 10.1128/JVI.01234-13. Epub 2013 Jun 26.

PMID:
23804647
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

Brauer MJ, Zhuang G, Schmidt M, Yao J, Wu X, Kaminker JS, Jurinka SS, Kolumam G, Chung AS, Jubb A, Modrusan Z, Ozawa T, James CD, Phillips H, Haley B, Tam RN, Clermont AC, Cheng JH, Yang SX, Swain SM, Chen D, Scherer SJ, Koeppen H, Yeh RF, Yue P, Stephan JP, Hegde P, Ferrara N, Singh M, Bais C.

Clin Cancer Res. 2013 Jul 1;19(13):3681-92. doi: 10.1158/1078-0432.CCR-12-3635. Epub 2013 May 17.

PMID:
23685835
[PubMed - indexed for MEDLINE]
Free Article
14.

First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus.

Kapur A, O'Connor-Semmes R, Hussey EK, Dobbins RL, Tao W, Hompesch M, Smith GA, Polli JW, James CD Jr, Mikoshiba I, Nunez DJ.

BMC Pharmacol Toxicol. 2013 May 13;14:26. doi: 10.1186/2050-6511-14-26.

PMID:
23668634
[PubMed - in process]
Free PMC Article
15.

Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models.

Weng KC, Hashizume R, Noble CO, Serwer LP, Drummond DC, Kirpotin DB, Kuwabara AM, Chao LX, Chen FF, James CD, Park JW.

Nanomedicine (Lond). 2013 Dec;8(12):1913-25. doi: 10.2217/nnm.12.209. Epub 2013 Apr 30.

PMID:
23631502
[PubMed - indexed for MEDLINE]
16.

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.

Hussey EK, Kapur A, O'Connor-Semmes R, Tao W, Rafferty B, Polli JW, James CD Jr, Dobbins RL.

BMC Pharmacol Toxicol. 2013 Apr 30;14:25. doi: 10.1186/2050-6511-14-25.

PMID:
23631443
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.

Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, Gupta N, Mueller S, James CD, Jenkins R, Sarkaria J, Zhang Z.

Genes Dev. 2013 May 1;27(9):985-90. doi: 10.1101/gad.217778.113. Epub 2013 Apr 19.

PMID:
23603901
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.

Akhavan D, Pourzia AL, Nourian AA, Williams KJ, Nathanson D, Babic I, Villa GR, Tanaka K, Nael A, Yang H, Dang J, Vinters HV, Yong WH, Flagg M, Tamanoi F, Sasayama T, James CD, Kornblum HI, Cloughesy TF, Cavenee WK, Bensinger SJ, Mischel PS.

Cancer Discov. 2013 May;3(5):534-47. doi: 10.1158/2159-8290.CD-12-0502. Epub 2013 Mar 26.

PMID:
23533263
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Aberrant miRNA expression in brain tumors: a subject attracting an increasing amount of attention.

James CD.

Neuro Oncol. 2013 Apr;15(4):405. doi: 10.1093/neuonc/not045. No abstract available.

PMID:
23530133
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Public Hospital Care: Equal for All or Equal for Some? Evidence From the Philippines.

James CD, Peabody J, Hanson K, Solon O.

Asia Pac J Public Health. 2013 Feb 17. [Epub ahead of print]

PMID:
23420059
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk